BeStock  
Stocks › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3516
$7.94 +$0.02 (+0.25%)
Pre-market · Oct 8, 7:40 am ET · After hours $7.84 -1.32%
Open$7.90
Prev close$7.92
Day range$7.79 – $8.23
Volume819.5K
Market cap$694.73M
P/E (TTM)–
Dividend yield–

OLMA Stock News

Headlines matching Olema Pharmaceuticals or the OLMA ticker, most recent first.

  • H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $36Market news · 21 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $16 NegativeMarket news · 15 Sep 2026 · Direct mention
  • Stifel Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $30 NegativeMarket news · 15 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $16 to $59Market news · 14 Sep 2026 · Direct mention
  • Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $59Market news · 11 Sep 2026 · Direct mention
  • Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40Market news · 20 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $46Market news · 17 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46Market news · 13 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy RatingMarket news · 11 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $20 to $59Market news · 11 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24Market news · 14 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $38Market news · 3 Jun 2026 · Direct mention
  • LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $24 NegativeMarket news · 3 Jun 2026 · Direct mention
  • Guggenheim Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $35 NegativeMarket news · 1 Jun 2026 · Direct mention
  • Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $62Market news · 1 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on OLMA.

Leave a comment

Scroll to Top